Chevallier, P., Huguet, F., Raffoux, E., Etienne, A., Leguay, T., Isnard, F., . . . Dombret, H. (2015). Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22(+) B-acute lymphoblastic leukemia patients: A phase II study. Haematologica.
シカゴスタイル引用形Chevallier, Patrice, et al. "Vincristine, Dexamethasone and Epratuzumab for Older Relapsed/refractory CD22(+) B-acute Lymphoblastic Leukemia Patients: A Phase II Study." Haematologica 2015.
MLA引用形式Chevallier, Patrice, et al. "Vincristine, Dexamethasone and Epratuzumab for Older Relapsed/refractory CD22(+) B-acute Lymphoblastic Leukemia Patients: A Phase II Study." Haematologica 2015.
警告: この引用は必ずしも正確ではありません.